← Open Payments lookup

PAUL BROWN: Open Payments

NPI 1003862376 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$552 in 27 payments from 10 companies in 2025. Trend: 2023 $988 · 2024 $684 · 2025 $552

Food & beverage: $552
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$129
PFIZER INC.4$103
Amgen Inc.4$84
Novo Nordisk Inc3$54
Axsome Therapeutics, Inc.2$54
Lilly USA, LLC2$42
Phadia US Inc.1$30
GlaxoSmithKline, LLC.1$25
Intra-Sana Laboratories1$17
Exact Sciences Corporation1$15

Products named: AIRSUPRA, PREVNAR 20, OTEZLA, Auvelity, MOUNJARO, FARXIGA, ImmunoCAP, REPATHA.

Industry payments across CA — which companies pay providers there.